Rodriguez-Gutierrez R, Gonzalez JG, Parmar D, Shaikh F, et al. Saroglitazar is non-inferior to fenofibrate in reducing triglyceride levels in hypertriglyceridemic patients in a randomized clinical trial. J Lipid Res 2022 May 20:100233. doi: 10.1016/j.jlr.2022.100233.
PMID: 35605678